Valuation: DBV Technologies

Market Cap 749M 874M 700M 640M 1.21B 83.39B 1.22B 8.26B 3.22B 42.06B 3.28B 3.21B 139B P/E 2026 *
-5.75x
P/E 2027 * -17.7x
Enterprise Value 673M 786M 630M 576M 1.09B 74.99B 1.1B 7.43B 2.9B 37.82B 2.95B 2.89B 125B EV / Sales 2026 *
263x
EV / Sales 2027 * 10.3x
Free-Float
99.85%
Yield 2026 *
-
Yield 2027 * -
1 day-0.93%
6 months-11.24%
Current year+9.23%
Current year 4.26
Extreme 4.26
4.8
1 year 3.9
Extreme 3.9
4.8
3 years 0
Extreme 0.0001
4.8
5 years 0
Extreme 0.0001
4.8
10 years 0
Extreme 0.0001
82.48
Manager TitleAgeSince
Chief Executive Officer 66 28/11/2018
Director of Finance/CFO 56 05/11/2023
Chief Operating Officer - 30/11/2023
Director TitleAgeSince
Director/Board Member 51 20/10/2015
Director/Board Member 62 20/06/2016
Director/Board Member 60 14/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%-.--% - - 842M
+3.84%+15.06%+79.07%+42.94% 372B
+0.69%+2.16%+24.25%-13.31% 70.21B
+0.63%+6.14%+52.21%+158.81% 12.33B
-0.50%+0.96%-2.77%-1.31% 8.49B
-2.31%-3.32%-14.66%-1.06% 4.89B
-1.19%-0.48%-27.57%+15.69% 4.54B
+1.34%-29.39%-24.38%+6.91% 3.04B
+0.55%-6.03%+1.07%+43.27% 2.62B
+2.75%-3.82%-14.32%-6.50% 2.05B
Average +0.49%+1.23%+8.10%+27.27% 53.32B
Weighted average by Cap. +3.06%+8.71%+65.46%+35.76%

Financials

2026 *2027 *
Net sales 2.56M 2.99M 2.4M 2.19M 4.14M 285M 4.17M 28.25M 11.02M 144M 11.22M 10.98M 476M 70.24M 81.98M 65.69M 60.07M 113M 7.82B 114M 775M 302M 3.95B 308M 301M 13.05B
Net income -174M -203M -163M -149M -281M -19.39B -284M -1.92B -749M -9.78B -763M -746M -32.35B -116M -135M -108M -99.2M -187M -12.92B -189M -1.28B -499M -6.52B -508M -497M -21.56B
Net Debt -75.46M -88.08M -70.57M -64.54M -122M -8.41B -123M -832M -325M -4.24B -331M -324M -14.02B -22.7M -26.5M -21.23M -19.41M -36.66M -2.53B -37M -250M -97.65M -1.28B -99.48M -97.33M -4.22B
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
170
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
2.530EUR
Average target price
3.637EUR
Spread / Average Target
+43.74%

Quarterly revenue - Rate of surprise